{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ORKA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ORKA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":10.58,"timestamp":1745352000000,"preClose":9.3,"halted":0,"volume":217195,"hourTrading":{"tag":"盘后","latestPrice":10.58,"preClose":10.58,"latestTime":"18:39 EDT","volume":167,"amount":1768.22,"timestamp":1745361572542},"delay":0,"floatShares":24529621,"shares":37440510,"eps":-4.225857,"marketStatus":"Closed","change":1.28,"latestTime":"04-22 16:00:00 EDT","open":9.46,"high":10.61,"low":9.12,"amount":2184702.170035,"amplitude":0.160215,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.225857,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":5,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":9.3,"preHourTrading":{"tag":"盘前","latestPrice":9.25,"preClose":9.3,"latestTime":"04:10 EDT","volume":2,"amount":18.060002,"timestamp":1745309450129},"postHourTrading":{"tag":"盘后","latestPrice":10.58,"preClose":10.58,"latestTime":"18:39 EDT","volume":167,"amount":1768.22,"timestamp":1745361572542},"volumeRatio":0.901123,"impliedVol":0.3209,"impliedVolPercentile":0.1282},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","floatShares":24529621,"roa":"--","roe":"--","lyrEps":-3.873702,"volumeRatio":0.901123,"shares":37440510,"dividePrice":0,"high":10.61,"amplitude":0.160215,"preClose":9.3,"low":9.12,"week52Low":5.485,"pbRate":"1.04","week52High":53.88,"institutionHeld":0.0223,"latestPrice":10.58,"eps":-4.225857,"divideRate":0,"volume":217195,"delay":0,"ttmEps":-4.225857,"open":9.46,"prevYearClose":19.39,"prevWeekClose":9.22,"prevMonthClose":10.26,"prevQuarterClose":10.26,"fiveDayClose":8.14,"twentyDayClose":12.36,"sixtyDayClose":12.19},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ORKA\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ORKA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529721198","title":"Oruka Therapeutics Inc  expected to post a loss of 52 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2529721198","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529721198?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:17","pubTimestamp":1745234225,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics Inc  expected to post a loss of52cents a share - Earnings Preview Oruka Therapeutics Inc ORKA.OQ ORKA.O is expected to report resultson April 23 (estimated) for the period ending Ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nL8N3QZ0FP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA"],"gpt_icon":0},{"id":"2517410724","title":"We're Not Very Worried About Oruka Therapeutics' (NASDAQ:ORKA) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2517410724","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517410724?lang=en_us&edition=fundamental","pubTime":"2025-03-08 21:49","pubTimestamp":1741441796,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?So should Oruka Therapeutics  shareholders be worried about its cash burn?In this article, we define cash burn as its annual  free cash flow, which is the amount of money a company spends each year to fund its growth. Let's start with an examination of the business' cash, relative to its cash burn.Check out our latest analysis for Oruka Therapeutics. When Might Oruka Therapeutics Run Out Of Money?If you would prefer to check out another company with better fundamentals, then do not miss this free list of interesting companies, that have HIGH return on equity and low debt or this list of stocks which are all forecast to grow.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/were-not-very-worried-oruka-134956436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","TQQQ","BK4139","BK4588","QLD","NDAQ","QID","IE00BKPKM429.USD","BK4585","SQQQ","IE00B64PRP62.GBP","ORKA","USAW.SI","USJW.SI","PSQ","LU2210150020.SGD","TSYW.SI","IE00B3QW5Z07.USD","NQmain","IE00BGHQF748.EUR",".IXIC","LU2095319765.USD","MNQmain","BK4112","LU2210149790.SGD"],"gpt_icon":1},{"id":"2517041562","title":"Oruka Therapeutics at Risk: Navigating Licensing Challenges and Partner Reliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2517041562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517041562?lang=en_us&edition=fundamental","pubTime":"2025-03-08 14:01","pubTimestamp":1741413661,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics, Inc. (ORKA) has disclosed a new risk, in the Trade Secrets category. Oruka Therapeutics, Inc. faces significant business risks ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oruka-therapeutics-at-risk-navigating-licensing-challenges-and-partner-reliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oruka-therapeutics-at-risk-navigating-licensing-challenges-and-partner-reliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","ORKA"],"gpt_icon":0},{"id":"2517430777","title":"Oruka Therapeutics Says ORKA-002 Preclinical Data Support Potential Extended Dosing Intervals","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430777","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517430777?lang=en_us&edition=fundamental","pubTime":"2025-03-08 00:25","pubTimestamp":1741364755,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics  said Friday that preclinical data on its monoclonal antibody ORKA-002 support potential extended dosing intervals and show equivalent potency to bimekizumab in plaque psoriasis.The company said ORKA-002 demonstrated a half-life of over 30 days in non-human primates, more than three times longer than bimekizumab and indicating a human half-life of about 50 days could allow dosing once every four months while a human half-life of approximately 75 days could allow dosing twice a year.Oruka also said ORKA-002, which is being developed to potentially treat chronic skin diseases including plaque psoriasis, exhibits comparable binding affinity and potency to bimekizumab, thus reducing development risks.The company said it expects to conduct a clinical trial of ORKA-002 and dose the first subject in Q3.Price: 10.25, Change: +0.18, Percent Change: +1.79","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ORKA"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORKA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-03","symbol":"ORKA","defaultRemindTime":1725370200000,"type":"split","dateTimestamp":1725336000000,"forFactor":12,"toFactor":1,"ratio":12},{"date":"2024-08-29","symbol":"ORKA","amount":1.613,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-26","defaultRemindTime":1724938200000,"name":"方舟生物医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-08-26","currency":"USD","dateTimestamp":1724904000000,"payDate":"2024-08-28"},{"market":"US","date":"2024-08-01","symbol":"ORKA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-04-25","symbol":"ORKA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-02-01","symbol":"ORKA","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1706763600000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":[{"executeDate":"2024-08-29","recordDate":"2024-08-26","paymentDate":"2024-08-28","value":1.613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORKA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.375,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1738641600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ORKA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ORKA","date":"2025-04-21","current":-3.779499,"percent":0.655172,"low":-5.124049,"twenty":-4.878914,"median":-4.198946,"eighty":-3.311366,"high":-2.779284,"avg":-4.115831,"sd":0.729732,"marketCap":345201502},"quantilePoints":[{"date":"2025-03-14","current":-4.566552,"twenty":-4.600166,"median":-4.533759,"eighty":-4.155287,"marketCap":417087281},{"date":"2025-03-21","current":-4.898591,"twenty":-4.788731,"median":-4.634189,"eighty":-4.465422,"marketCap":447414094},{"date":"2025-03-28","current":-4.898591,"twenty":-4.90187,"median":-4.734621,"eighty":-4.543597,"marketCap":447414094},{"date":"2025-04-04","current":-3.656521,"twenty":-4.90187,"median":-4.68543,"eighty":-4.155287,"marketCap":333969349},{"date":"2025-04-11","current":-3.021139,"twenty":-4.898591,"median":-4.546056,"eighty":-3.567158,"marketCap":275936558},{"date":"2025-04-17","current":-3.529445,"twenty":-4.883833,"median":-4.205819,"eighty":-3.28595,"marketCap":322362791},{"date":"2025-04-21","current":-3.779499,"twenty":-4.878914,"median":-4.198946,"eighty":-3.311366,"marketCap":345201502}],"updateTime":1745380195991}}}